FR2672596B1 - Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. - Google Patents

Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Info

Publication number
FR2672596B1
FR2672596B1 FR9101374A FR9101374A FR2672596B1 FR 2672596 B1 FR2672596 B1 FR 2672596B1 FR 9101374 A FR9101374 A FR 9101374A FR 9101374 A FR9101374 A FR 9101374A FR 2672596 B1 FR2672596 B1 FR 2672596B1
Authority
FR
France
Prior art keywords
new
medicaments
application
pharmaceutical compositions
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9101374A
Other languages
English (en)
Other versions
FR2672596A1 (fr
Inventor
Clemence Francois
Fortin Michel
Haesslein Jean-Luc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR9101374A priority Critical patent/FR2672596B1/fr
Priority to MX9200299A priority patent/MX9200299A/es
Priority to AT92400296T priority patent/ATE205832T1/de
Priority to EP92400296A priority patent/EP0498723B1/fr
Priority to ES92400296T priority patent/ES2161688T3/es
Priority to JP4775092A priority patent/JP3599351B2/ja
Priority to DE69232060T priority patent/DE69232060T2/de
Priority to AU10709/92A priority patent/AU658163B2/en
Priority to DK92400296T priority patent/DK0498723T3/da
Priority to PT92400296T priority patent/PT498723E/pt
Priority to KR1019920001716A priority patent/KR100260010B1/ko
Priority to IE039692A priority patent/IE920396A1/en
Priority to CA002060750A priority patent/CA2060750A1/fr
Priority to SU5011269A priority patent/RU2119481C1/ru
Priority to HU9200366A priority patent/HUT64522A/hu
Priority to BR929200424A priority patent/BR9200424A/pt
Priority to ZA92895A priority patent/ZA92895B/xx
Priority to CN92100804A priority patent/CN1063869A/zh
Publication of FR2672596A1 publication Critical patent/FR2672596A1/fr
Application granted granted Critical
Publication of FR2672596B1 publication Critical patent/FR2672596B1/fr
Priority to US08/583,637 priority patent/US5817674A/en
Priority to US09/071,586 priority patent/US6004979A/en
Priority to GR20010401668T priority patent/GR3036805T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR9101374A 1991-02-07 1991-02-07 Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. Expired - Fee Related FR2672596B1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR9101374A FR2672596B1 (fr) 1991-02-07 1991-02-07 Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
MX9200299A MX9200299A (es) 1991-02-07 1992-01-24 Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
EP92400296A EP0498723B1 (fr) 1991-02-07 1992-02-05 Dérivés bicycliques azotés, leur procédé de préparation, leur application à titre de médicament et les compositions pharmaceutiques les renfermant
ES92400296T ES2161688T3 (es) 1991-02-07 1992-02-05 Derivados biciclicos nitrogenados, su procedimiento de preparacion, su aplicacion como medicamentos, y composiciones farmaceuticas que los contienen.
JP4775092A JP3599351B2 (ja) 1991-02-07 1992-02-05 新規の窒素系二環式誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
DE69232060T DE69232060T2 (de) 1991-02-07 1992-02-05 Stickstoff enthaltende bicyclische Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen
AU10709/92A AU658163B2 (en) 1991-02-07 1992-02-05 New nitrogenous bicyclic derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
DK92400296T DK0498723T3 (da) 1991-02-07 1992-02-05 Dobbeltcykliske nitrogenforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
PT92400296T PT498723E (pt) 1991-02-07 1992-02-05 Derivados biciclicos azotados processo para a sua preparacao sua aplicacao a titulo de medicamento e composicoes farmaceuticas que os contem
AT92400296T ATE205832T1 (de) 1991-02-07 1992-02-05 Stickstoff enthaltende bicyclische verbindungen, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen
KR1019920001716A KR100260010B1 (ko) 1991-02-07 1992-02-06 질소 함유 비시클릭 유도체, 그의 제조 방법, 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
CA002060750A CA2060750A1 (fr) 1991-02-07 1992-02-06 Derives bicycliques azotes, leur procede de preparation, nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
SU5011269A RU2119481C1 (ru) 1991-02-07 1992-02-06 Бициклические азотсодержащие производные или их соли с минеральными и органическими кислотами или основаниями, способы их получения и фармацевтическая композиция на их основе
HU9200366A HUT64522A (en) 1991-02-07 1992-02-06 Process for producing of bicyclic compounds containing nitrogen and medical preparatives containing them as active agents
IE039692A IE920396A1 (en) 1991-02-07 1992-02-06 New nitrogenous bicyclic derivatives, their preparation¹process, the new intermediates obtained, their use as¹medicaments and the pharmaceutical compositions containing¹them
ZA92895A ZA92895B (en) 1991-02-07 1992-02-07 Nitrogenous bicyclic derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them
BR929200424A BR9200424A (pt) 1991-02-07 1992-02-07 Processo para preparar produtos,processo para preparar composicoes farmaceuticas e utilizacao de produtos
CN92100804A CN1063869A (zh) 1991-02-07 1992-02-07 新的含氮双环衍生物,其制备方法,由此得到的新的中间体,其药物用途和含这类物质的药物组合物
US08/583,637 US5817674A (en) 1991-02-07 1996-01-05 Quinoline compounds
US09/071,586 US6004979A (en) 1991-02-07 1998-05-01 Nitrogenous bicycles
GR20010401668T GR3036805T3 (en) 1991-02-07 2001-10-04 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101374A FR2672596B1 (fr) 1991-02-07 1991-02-07 Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Publications (2)

Publication Number Publication Date
FR2672596A1 FR2672596A1 (fr) 1992-08-14
FR2672596B1 true FR2672596B1 (fr) 1995-07-13

Family

ID=9409441

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9101374A Expired - Fee Related FR2672596B1 (fr) 1991-02-07 1991-02-07 Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Country Status (3)

Country Link
FR (1) FR2672596B1 (fr)
RU (1) RU2119481C1 (fr)
ZA (1) ZA92895B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419788A (en) * 1972-08-02 1975-12-31 Pfizer Herbicidal method using 2-trifuluromethyl-4-quinolinols
US3936461A (en) * 1973-09-24 1976-02-03 Warner-Lambert Company Substituted 4-benzylquinolines
US4025629A (en) * 1974-01-07 1977-05-24 The Upjohn Company P-(trifluoromethylquinolylamino)benzamides, pharmaceutical dosage forms and method of treatment
FR2377400A2 (fr) * 1977-01-18 1978-08-11 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
GB2143814A (en) * 1983-07-29 1985-02-20 Showa Denko Kk Quinazolines
PH22302A (en) * 1985-02-11 1988-07-22 Fujisawa Pharmaceutical Co Piperidine compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
YU155290A (sh) * 1989-08-11 1993-05-28 Imperial Chemical Industries Plc. Dusikove spojine
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same

Also Published As

Publication number Publication date
RU2119481C1 (ru) 1998-09-27
ZA92895B (en) 1993-04-28
FR2672596A1 (fr) 1992-08-14

Similar Documents

Publication Publication Date Title
FR2586683B1 (fr) Nouveaux derives de neothramycine, leur procede de preparation et leur application en tant que medicaments
FR2664592B1 (fr) Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2676056B1 (fr) Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2582309B1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2724654B1 (fr) Nouveaux derives de l'acide gallique, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2612189B1 (fr) Nouveaux derives de la pyridine, leur procede de preparation et les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions les renfermant
FR2671551B1 (fr) Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2747680B1 (fr) Nouveaux steroides, leur application a titre de medicaments, leur procede de preparation, les intermediaires de ce procede et les compositions pharmaceutiques les renfermant
FR2691459B1 (fr) Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2669633B1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663028B1 (fr) Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2740135B1 (fr) Nouveaux derives de pyrazoles acides, leur procede de preparation, leur application a titre de medicaments, leur nouvelle utilisation et les compositions pharmaceutiques les renfermant
FR2733233B1 (fr) Nouveaux derives de quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2672596B1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2680510B1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2706459B1 (fr) Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
FR2672597B1 (fr) Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2673629B1 (fr) Nouveaux derives du benzopyrane leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2617481B1 (fr) Nouveaux derives de la tetrahydropyridine, leur procede de preparation et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2681598B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant.
FR2673943B1 (fr) Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2670489B1 (fr) Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2617164B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2660310B1 (fr) Nouveaux derives de la 4h-pyrrolo[1,2a] thieno[2,3-f] diazepine[1,4], leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2649981B1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
TP Transmission of property
TP Transmission of property
ST Notification of lapse